Provided by Tiger Fintech (Singapore) Pte. Ltd.

Intellicheck Mobilisa

2.59
-0.1000-3.72%
Volume:53.63K
Turnover:141.39K
Market Cap:51.18M
PE:-118.94
High:2.79
Open:2.68
Low:2.57
Close:2.69
Loading ...

VSee Healthl renews $2M two-year contract with IDN hospital system

TIPRANKS
·
06 Feb

Intellicheck (NASDAQ:IDN) investors are sitting on a loss of 69% if they invested five years ago

Simply Wall St.
·
05 Feb

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Zacks
·
04 Feb

Imaging giant Pro Medicus notches all time high on $50M+ deal

The Market Herald
·
04 Feb

Pro Medicus shares jump to record high on big news

MotleyFool
·
04 Feb

Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock

Zacks
·
03 Feb

Solid Biosciences Receives FDA Fast Track Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

GlobeNewswire
·
21 Jan

Solid Biosciences Outlines Key Priorities for Advancing Diversified Neuromuscular and Cardiac Development Pipeline and Establishing Leadership in Precision Genetic Medicines

GlobeNewswire
·
16 Jan

Should You Think About Buying Intellicheck, Inc. (NASDAQ:IDN) Now?

Simply Wall St.
·
16 Jan

SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia

Zacks
·
08 Jan

We're Not Worried About Intellicheck's (NASDAQ:IDN) Cash Burn

Simply Wall St.
·
26 Dec 2024

CytoMed Therapeutics And 2 Other US Penny Stocks To Watch

Simply Wall St.
·
06 Dec 2024

Northland Securities Keeps Their Hold Rating on Intellicheck Mobilisia (IDN)

TIPRANKS
·
14 Nov 2024

D.A. Davidson Sticks to Its Hold Rating for Intellicheck Mobilisia (IDN)

TIPRANKS
·
14 Nov 2024

Intellicheck Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Nov 2024

Intellicheck Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024